How could this research be used to change shielding advice in the UK?
Starting the development of a risk tool/calculator is an important first step. Deciding how the finished tool will be used across the health and care system will involve discussions with experts in clinical practice, public health and policy as well as patient groups, charities and user group research.
One of the areas we are exploring is whether we can turn it into a clinical tool to support conversations between patients and doctors/nurses, to provide more targeted advice to the clinically vulnerable, based on levels of individual risk.